Lymphotoxin-β and TNF regulation in T cell subsets: Differential effects of PGE2

Cytokine

Volumn 9, Issue 3, 1997, Pages 157-165

  Ferreri, Nicholas R ^a   Millet, Isabelle ^b   Askari, Bardia ^a   Magnani, Patricia ^a   Ruddle, Nancy H ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

LT ; PGE2; T lymphocytes; TNF

Indexed keywords

CD4 ANTIGEN; CYCLOHEXIMIDE; CYTOKINE; INTERLEUKIN 3; INTERLEUKIN 4; LYMPHOTOXIN; MESSENGER RNA; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION REGULATION; HELPER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031105359     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0150     Document Type: Article

References (50)

1. 1. Beutler B, Cerami A (1989) The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 7:625-655.
2. 2. Paul NL, Ruddle NH (1988) Lymphotoxin. Annu Rev Immunol 6:407-438.
3. 3. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL (1992) Expression of surface lymphotoxin and tumor necrosis factor on activated T,B, and natural killer cells. J Immunol 149:3881-3888.
4. 4. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine GB, Foley SF, Ware CF (1993) Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847-856.
5. 5. Ware CF, VanArsdale TL, Crowe PD, Browning JL (1995) The ligands and receptors of the lymphotoxin system. Curr Top Microbiol Immunol 198:175-218.
6. 6. Androlewicz MJ, Browning JL, Ware CF (1992) Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J Biol Chem 267:2542-2547.
7. 7. Browning JL, Dougas I, Ngam ek A, Bourdon PR, Ehrenfels BN, Miatkowski K, Zafari M, Yampaglia AM, Lawton P, Meier W, et al (1995) Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J Immunol 154:33-46.
8. 8. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Bhrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA (1994) A lymphotoxin-β-specific receptor. Science 264:707-710.
9. 9. Force WR, Walter BN, Hession C, Tizard R, Kozak CA, Browning JL, Ware CF (1995) Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. J Immunol 155:5280-5288.
10. 10. Erickson SL, deSauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillet N, Sheehan KCF, Schreiber RD, Goeddel DV, Moore MW (1994) Decreased sensitivity to tumour-necrosis factor but normal T cell development in TNF-receptor-2-deficient mice. Nature 372:560-563.
11. 11. Neumann B, Luz A, Pfeffer K, Holzmann B (1996) Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med 184:259-264.
12. 12. De togni P, Goellner J, Ruddle NH, Streeter PR, Pick A, Mariathasan S, Smith SC, Carlson R, Schornick LP, Strauss-Schoenberger SJ, Russell JH, Karr R, Chaplin DD (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703-707.
13. 13. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962.
14. 14. Stout Rd, Bottomly KD (1989) Antigen-sepcific activity of effector macrophages by IFNγ-producing (Th1) T cell clones use of IL-4 producing (Th2) T cell clones to activate effector function in macrophages. J Immunol 142:760-765.
15. h cell clone II. Delayed-type hypersensitivity is mediated by clones. J Immunol 138:3688-3694.
16. 16. Coffman RL, Seymour BWP, Lebman DA, Hiraki DD, Christiansen JA, Shrader B, Cherwinski H, Savelkoul HFJ, Finkelman FD, Bond MW, Mosmann TR (1988) The role of helper T cell products in mouse B cell differentiation and isotypes regulation. Immunol Rev 102:5-28.
17. 17. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman L (1986) Two types of murine helper T cell clone. Inhibition according to profiles of lymphokines activities. J Immunol 136:2348-2357.
18. 18. Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokines production by Th1 clones. J Exp Med 170:2081-2095.
19. 19. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A (1991) IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451.
20. 20. Millet I, Ruddle NH (1994) Differential regulation of lymphotoxin (LTα), lymphotoxin-β (LT-β) and TNF-α in murine T cell clones activated through the TCR. J Immunol 152:4336-4346.
21. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 150:5321-5329.
22. 2) on IL-3/granulocyte-macrophage colony-stimulating factor production by T helper cells . J Immunol 150:1680-1690.
23. 2-dependent induction of granulocyte-macrophage colony-stimulating factor secretion by cloned murine helper T cells. J Immunol 142:813-818.
24. 2 inhibits production of Th1 lymphokines but not of Th2 lympholines. J Immunol 146:108-113.
25. 2 in T-cell subsets. Immunomethods 2:245-254.
26. 26. Ferreri NR, Sarr T, Askenase PW, Ruddle NH (1992) Molecular regulation of tumor necrosis factor-α and lymphotoxin production in T cells. J Biol Chem 267:9443-9449.
27. 27. Sheehan KCF, Ruddle NH, Schreiber RD (1989) Generation and characterization of hamster monoclonal antiboides that neutralize murine tumor necrosis factors. J Immunol 142:3884-3893.
28. 28. Beutler B, Krochin N, Milsark IW, Leudke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-980.
29. 29. Collart MA, Belin D, Vassalli J-D, de Kossodo S, Vassalli P (1986) Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 164:2113-2118.
30. 30. Zubiaga AM, Munoz E, Huber BT (1991) Superinduction of IL-2 gene transcription in the presence of cycloheximide. J Immunol 146:3857-3863.
31. 31. Sen R, Baltimore D (1986) Inducibility of κ immunoglobulin enhancer-binding protein NF-kaβ by a postranslational mechanism. Cell 47:921-928.
32. 2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways. J Exp Med 178:1813-1817.
33. 33. McCaffrey PG, Goldfeld AE, Rao A (1994) The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription. J Biol Chem 269:30445-30450.
34. 34. Goldfeld AE, McCaffrey PG, Strominger JL, Rao A (1993) Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J Exp Med 178:1365-1379.
35. H2 clones. J Immunol 144: 4110-4120.
36. 36. Munoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT (1990) Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 172:95-103.
37. h2) cell lines in signalling pathways for induction of contact-dependent T cell help. Eur J Immunol 22:85-93.
38. 38. Nordstedt C, Kvanta A, Van de Ploeg I, Fredholm BB (1989) Dual effects of protein-kinase-C on receptor-stimulated cAMP accumulation in a human T-cell leukemia line. Eur J Pharmacol 172:51-60.
39. 39. Muallem S, Merritt BS, Green J, Kleeman CR, Yamaguchi DT (1989) Classification of prostaglandin receptors based on coupling to signal transduction systems. Biochem J 263:769-774.
40. 40. Sonnenburg WK, Zhu J, Smith WL (1990) A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells. J Biol Chem 265:8479-8483.
41. 2 subtype. Invest Ophthalmol Vis Sci 32:360-365.
42. 42. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni M-P, Macchia D, Maggi E, Del Prete G, Romagnani S (1992) IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cells clones. J Immunol 149:2977-2983.
43. 43. Gautam SC, Chikkala NF, Hamilton TA (1992) Anti-inflammatory action of IL-4 Negative regulation of contact sensitivity to trinitrochlorobenzene. J Immunol 148:1411-1425.
44. 44. Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic DL (1992) IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J Immunol 148:3820-3829.
45. 45. Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411-452.
46. 4 during T cell activation. J Immunol 142:4169-4175.
47. 47. Ruddle NH, Bergman CM, McGrath KM, LIngenheld EG, Grunnet ML, Padula SJ, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172: 1193-1200.
48. 48. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
49. 49. Kamdar SJ, Evans R (1992) Modifications of the guanidine hydrochloride procedure for the extraction of RNA: isolation from a variety of tissues and adherent/nonadherent cell types. Biotech 12:632-638.
50. 50. Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.